M Marinò

Author PubWeight™ 6.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases. Clin Endocrinol (Oxf) 1992 0.91
2 Absence of primary hypothyroidism and goiter in Slc26a4 (-/-) mice fed on a low iodine diet. J Endocrinol Invest 2010 0.81
3 Circulating thyroid autoantibodies in a sample of Italian octo-nonagenarians: relationship to age, sex, disability, and lipid profile. Aging (Milano) 1999 0.81
4 Total thyroid ablation in Graves' orbitopathy. J Endocrinol Invest 2015 0.81
5 An update on medical management of Graves' ophthalmopathy. J Endocrinol Invest 2005 0.80
6 Binding, uptake, and degradation of internalized thyroglobulin in cultured thyroid and non-thyroid cells. J Endocrinol Invest 2010 0.78
7 Quercetin decreases proliferation of orbital fibroblasts and their release of hyaluronic acid. J Endocrinol Invest 2010 0.78
8 Chronic recurrent stress due to panic disorder does not precipitate Graves' disease. J Endocrinol Invest 1998 0.78
9 Impaired thyroglobulin (Tg) secretion by FRTL-5 cells transfected with soluble receptor associated protein (RAP): evidence for a role of RAP in the Tg biosynthetic pathway. J Endocrinol Invest 2003 0.78
10 Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy. J Endocrinol Invest 2004 0.78
11 Influences of thyroid diseases in diabetic pregnant women. Ann Ist Super Sanita 1997 0.77
12 Sequencing of the entire coding region of the receptor associated protein (RAP) in patients with primary hypothyroidism of unknown origin. J Endocrinol Invest 2007 0.77
13 Thyroglobulin autoantibodies switch to immunoglobulin (Ig)G1 and IgG3 subclasses and preserve their restricted epitope pattern after 131I treatment for Graves' hyperthyroidism: the activity of autoimmune disease influences subclass distribution but not epitope pattern of autoantibodies. Clin Exp Immunol 2014 0.75
14 Poorly specific binding of thyroglobulin to orbital fibroblasts from patients with Graves' ophthalmopathy. J Endocrinol Invest 2005 0.75
15 [Radiometabolic therapy of the autonomous thyroid nodule]. Minerva Endocrinol 1993 0.75
16 Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma. J Endocrinol Invest 1994 0.75
17 False negative results observed in anti-thyroid peroxidase autoantibody determination by competitive radioimmunoassays using monoclonal antibodies. Eur J Endocrinol 1994 0.75
18 Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer. J Endocrinol Invest 2004 0.75
19 Kidney abnormalities in low density lipoprotein receptor associated protein knockout mice. J Endocrinol Invest 2008 0.75